Literature DB >> 15928416

Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniae and Escherichia coli.

S Ananthan1, A Subha.   

Abstract

PURPOSE: Porins are outer membrane protein (OMP) that form water filled channels that permit the diffusion of small hydrophilic solutes like beta-lactam antibiotics across the outer membrane. Two major porins that facilitate diffusion of antimicrobials have been described in Klebsiella spp. and Escherichia coli. The present study was carried out to examine the role of porins among Extended Spectrum beta-Lactamase (ESBL) and AmpC beta-Lactamase positive strains of Klebsiella spp. and E.coli.
METHODS: Preparation of OMP from phenotypically characterized clinical isolates K.pneumoniae and E.coli and the separation of the proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis were performed as per a previously described procedure.
RESULTS: OMP analysis revealed that cefoxitin and ceftazidime resistance was mediated by loss of a porin Omp K35 in the isolates of K.pneumoniae and E.coli.
CONCLUSIONS: Loss of porin mediated resistance mechanism against cefoxitin was observed among the multidrug resistant K.pneumoniae and E.coli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15928416     DOI: 10.4103/0255-0857.13867

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  23 in total

1.  Therapeutic challenges of ESBLS and AmpC beta-lactamase producers in a tertiary care center.

Authors:  Naveen Grover; A K Sahni; S Bhattacharya
Journal:  Med J Armed Forces India       Date:  2012-07-17

2.  Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.

Authors:  Raphaël Lepeule; Etienne Ruppé; Patrick Le; Laurent Massias; Françoise Chau; Amandine Nucci; Agnès Lefort; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

3.  The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them.

Authors:  Bhaskar Thakuria; Kingshuk Lahon
Journal:  J Clin Diagn Res       Date:  2013-06-01

4.  Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli.

Authors:  H Guet-Revillet; A Emirian; M Groh; B Nebbad-Lechani; E Weiss; O Join-Lambert; E Bille; V Jullien; J R Zahar
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

5.  Occurrence of Plasmid-Mediated AmpC β-Lactamases Among Escherichia coli and Klebsiella pneumoniae Clinical Isolates in a Tertiary Care Hospital in Bangalore.

Authors:  B Sasirekha; Srividya Shivakumar
Journal:  Indian J Microbiol       Date:  2011-08-11       Impact factor: 2.461

6.  Extended spectrum β-lactamase producing Enterobacteriaceae & antibiotic co-resistance.

Authors:  S M Rudresh; T Nagarathnamma
Journal:  Indian J Med Res       Date:  2011-01       Impact factor: 2.375

7.  Incidence of temonera, sulphuhydryl variables and cefotaximase genes associated with β-lactamase producing escherichia coli in clinical isolates.

Authors:  Ibeh Nnana Isaiah; Bikwe Thomas Nche; Ibeh Georgina Nwagu; Ibeh Isaiah Nwagu
Journal:  N Am J Med Sci       Date:  2011-12

8.  Antimicrobial susceptibility pattern of extended-spectrum beta- lactamase producing Klebsiella pneumoniae clinical isolates in an Indian tertiary hospital.

Authors:  Amit Kumar Singh; Sonali Jain; Dinesh Kumar; Ravinder Pal Singh; Hitesh Bhatt
Journal:  J Res Pharm Pract       Date:  2015 Jul-Sep

9.  Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran.

Authors:  Mohammad Sadegh Rezai; Ebrahim Salehifar; Alireza Rafiei; Taimour Langaee; Mohammadreza Rafati; Kheironesa Shafahi; Gohar Eslami
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

10.  Prevalence of ESBL-Producing Klebsiella pneumoniae Isolates in Tertiary Care Hospital.

Authors:  Vemula Sarojamma; Vadde Ramakrishna
Journal:  ISRN Microbiol       Date:  2011-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.